Celldex Therapeutics (FRA:TCE2) Shares Buyback Ratio % : -0.72 (As of May. 14, 2025)

View and export this data going back to 2007. Start your Free Trial

What is Celldex Therapeutics Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Celldex Therapeutics's current shares buyback ratio was -0.72%.

Celldex Therapeutics Shares Buyback Ratio % Historical Data

The historical data trend for Celldex Therapeutics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celldex Therapeutics Shares Buyback Ratio % Chart

Celldex Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Shares Buyback Ratio %

Get a 7-Day Free Trial

-133.35

-17.99

-1.01

-18.39

-18.77

Celldex Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Shares Buyback Ratio %	Get a 7-Day Free Trial															-17.94	-0.56	-0.10	-0.05	-0.01

Celldex Therapeutics Shares Buyback Ratio % Calculation

Celldex Therapeutics's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(55.883	-	66.375)	/	55.883
	=	-18.77%

Celldex Therapeutics's Shares Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2024 )	-	Shares Outstanding (EOP) (A: Mar. 2025 ))	/	Shares Outstanding (EOP) (A: Dec. 2024 )
	=	(66.375	-	66.383)	/	66.375
	=	-0.01%

Celldex Therapeutics Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Celldex Therapeutics's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Celldex Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celldex Therapeutics Inc (FRA:TCE2) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

CLDX:USA TCE2:Germany

Address

53 Frontage Road, Suite 220, Perryville III Building, Hampton, NJ, USA, 08827

Website

https://www.celldex.com

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Celldex Therapeutics Headlines

No Headlines